656 results match your criteria: "Regional Universitaire de Lille[Affiliation]"

Are serum C3 levels or kidney C3 deposits useful markers for predicting outcomes in patients with ANCA-associated vasculitis?

J Transl Autoimmun

December 2023

Département de Néphrologie et Transplantation d'organes, Centre de référence des Maladies rénales rares, Groupe Français d'études des Vascularites, Centre Hospitalier Universitaire de Toulouse, Toulouse, France.

Introduction: Complement activation emerged as a key actor of anti-neutrophil cytoplasmic antibodies-associated vasculitis (AAV). Whether serum levels of C3 (sC3) or C3 kidney deposition may help to refine the prognosis of AAV remains elusive.

Methods: Retrospective multicentric study that included 154 patients with a first flare of AAV and sC3 (n = 143) or C3 kidney staining (n = 95) available at diagnosis.

View Article and Find Full Text PDF
Article Synopsis
  • Clinical events can occur after percutaneous coronary intervention (PCI), especially in complex cases, and using advanced intracoronary imaging and pressure guidewires may help reduce these risks.
  • The OPTI-XIENCE study is an international, multicenter prospective observational study involving 1,064 patients with specific high-risk characteristics undergoing stent implantation, monitoring them for 12 months.
  • The study aims to evaluate the effectiveness of using these intracoronary tools, with the primary focus on the rate of target lesion failure after one year, while also assessing additional cardiovascular outcomes.
View Article and Find Full Text PDF

Objectives: According to the WHO, more than 50 million people have epilepsy. Among them, nearly 80% of patients with epilepsy live in developing countries and 75% of them do not have access to treatment. The ketogenic diet (KD) has been shown as an effective alternative for patients with drug-resistant epilepsy.

View Article and Find Full Text PDF

Microsurgical resection of gliomas of the cingulate gyrus: a systematic review and meta-analysis.

Neurosurg Rev

September 2023

Neurosurgery Service and Gamma Knife Center, Lausanne University Hospital (CHUV), Rue du Bugnon 44-46, BH-08, CH-1011, Lausanne, Switzerland.

Cingulate gyrus gliomas are rare among adult, hemispheric diffuse gliomas. Surgical reports are scarce. We performed a systematic review of the literature and meta-analysis, with the aim of focusing on the extent of resection (EOR), WHO grade, and morbidity and mortality, after microsurgical resection of gliomas of the cingulate gyrus.

View Article and Find Full Text PDF
Article Synopsis
  • * In a study of 1091 adult patients, 12.9% had KMT2A-r, with a 5-year relapse rate of 40.7% and overall survival rate of 53.3%. The presence of specific gene alterations like TP53 and IKZF1 correlated with significantly worse outcomes.
  • * The analysis showed that measuring minimal residual disease (MRD) using KMT2A markers was more reliable than other methods, indicating that patients responding well early
View Article and Find Full Text PDF

Independently, both 5-aminolevulinic acid (5-ALA) and intraoperative neuromonitoring (IONM) have been shown to improve outcomes with high-grade gliomas (HGG). The interplay and overlap of both techniques are scarcely reported in the literature. We performed a systematic review and meta-analysis focusing on the concomitant use of 5-ALA and intraoperative mapping for HGG located within eloquent cortex.

View Article and Find Full Text PDF

First-in-human study of the K-Clip™ transcatheter annular repair system for severe functional tricuspid regurgitation.

Int J Cardiol

November 2023

Department of Cardiology, Zhongshan Hospital, Shanghai Institute of Cardiovascular Disease, Fudan University, Shanghai, China; National Clinical Research Center for Interventional Medicine, Shanghai, China.

Background: Severe TR is associated with impaired prognosis while limited interventional options available. The purpose of this observational first-in-human experience with the K-Clip™ transcatheter tricuspid annular reconstruction system is to investigate its feasibility, safety as well as short-term clinical impact on patients with severe functional tricuspid regurgitation (TR).

Methods: In this compassionate-use, prospective, multi-center, single-arm study, 15 patients with severe symptomatic functional TR were treated with the K-Clip™ system and followed up at 30 days after discharge.

View Article and Find Full Text PDF

Proteinuria reduction with SGLT2 inhibitors in a patient treated with tyrosine kinase inhibitor lenvatinib.

J Nephrol

January 2024

Department of Diabetology, Endocrinology, Metabolism and Nutrition, Centre Hospitalier Regional Universitaire de Lille, Lille University Hospital, Lille, France.

We describe the case of a 66-year-old woman treated with tyrosine kinase inhibitor Lenvatinib for thyroid carcinoma who had persistent proteinuria above 2 g/24 h despite maximal dose of angiotensin-converting enzyme inhibitor. We initiated a treatment with SGLT2 inhibitor Dapagliflozin. Three months after Dapagliflozin initiation, her proteinuria decreased to 1 g/24 h, and after 6 months of follow-up was 0.

View Article and Find Full Text PDF
Article Synopsis
  • * A study analyzed a large international group of patients with specific genetic variants (RUNX1, GATA2, DDX41) to identify unique genetic patterns linked to the development of these malignancies, particularly noting different tendencies for early-onset clonal hematopoiesis (CH).
  • * Findings suggest that further monitoring and clinical trials should focus on specific genetic variants to improve preemptive treatments and surveillance for patients, especially those with RUNX1 and DDX41 mutations.
View Article and Find Full Text PDF

Brief Report: Severe Sotorasib-Related Hepatotoxicity and Non-Liver Adverse Events Associated With Sequential Anti-Programmed Cell Death (Ligand)1 and Sotorasib Therapy in KRAS-Mutant Lung Cancer.

J Thorac Oncol

October 2023

Respiratory Department and Early Phase, Louis Pradel Hospital, Hospices Civils de Lyon Cancer Institute, Lyon, France; Oncopharmacology Laboratory, Cancer Research Center of Lyon, Unité mixte de recherche (UMR) Institut national de la santé et de la recherche médicale (INSERM) 1052 Centre national de la recherche scientifique (CNRS) 5286, Lyon, France; Université Claude Bernard, Université de Lyon, Lyon, France. Electronic address:

Introduction: Sequential anti-programmed cell death protein 1 (PD-1) or anti-programmed death-ligand 1 (PD-L1) followed by small targeted therapy use is associated with increased prevalence of adverse events (AEs) in NSCLC. KRASG12C inhibitor sotorasib may trigger severe immune-mediated hepatotoxicity when used in sequence or in combination with anti-PD-(L)1. This study was designed to address whether sequential anti-PD-(L)1 and sotorasib therapy increases the risk of hepatotoxicity and other AEs.

View Article and Find Full Text PDF

Introduction: The combined use of intraoperative MRI and awake surgery is a tailored microsurgical resection to respect functional neural networks (mainly the language and motor ones). Intraoperative MRI has been classically considered to increase the extent of resection for gliomas, thereby reducing neurological deficits. Herein, we evaluated the combined technique of awake microsurgical resection and intraoperative MRI for primary brain tumours (gliomas, metastasis) and epilepsy (cortical dysplasia, non-lesional, cavernomas).

View Article and Find Full Text PDF

mutational status affects myelodysplastic syndrome evolution to chronic myelomonocytic leukemia.

Haematologica

November 2023

Univ Paris Est Créteil, INSERM, IMRB, F-94010 Créteil, France; AP-HP, Hôpital Henri Mondor, Département d'Hématologie et Immunologie, F-94010 Créteil.

View Article and Find Full Text PDF

Background: In proximal occlusions, the effect of reperfusion therapies may differ between slow or fast progressors. We investigated the effect of intravenous thrombolysis (IVT) (with alteplase) plus mechanical thrombectomy (MT) versus thrombectomy alone among slow versus fast stroke progressors.

Methods: The SWIFT-DIRECT trial data were analyzed: 408 patients randomized to IVT+MT or MT alone.

View Article and Find Full Text PDF
Article Synopsis
  • Momelotinib is the first inhibitor targeting both JAK1, JAK2, and ACVR1, showing benefits in treating symptoms of myelofibrosis (MF), like splenomegaly and anemia.
  • A long-term analysis pooled data from three phase 3 studies involving 725 MF patients, with some remaining on momelotinib for over 5 years.
  • The treatment had a manageable safety profile, with diarrhea as the most common side effect, and no increase in serious adverse events over time.
View Article and Find Full Text PDF
Article Synopsis
  • - The text discusses a case of a 27-year-old male patient who underwent awake surgery for a cavernous malformation in a sensitive brain area that caused hemorrhage and epilepsy, using advanced imaging techniques.
  • - The surgery involved a combination of preoperative diffusion tensor imaging, neuronavigation, and intraoperative MRI to successfully remove the malformation, despite patient movement during the procedure.
  • - Post-surgery, the patient experienced a single seizure but showed no significant complications, and follow-up imaging confirmed complete removal of the malformation with normal cognitive function reported in neuropsychological tests.
View Article and Find Full Text PDF

Socio-professional impact and quality of life of cryopyrin-associated periodic syndromes in 54 patients in adulthood.

Clin Exp Rheumatol

October 2023

Service de Médecine Interne et Immunologie Clinique, Centre de Référence des Maladies Autoimmunes Systémiques Rares du Nord et Nord-Ouest de France (CeRAINO), Université de Lille, Inserm, CHU Lille, U1286 - INFINITE - Institute for Translational Research in Inflammation, Lille, France.

Objectives: Cryopyrin-associated periodic syndromes (CAPS) belongs to the group of hereditary recurrent fever disorders characterised by interleukin1β-mediated systemic inflammation. Specific treatment by IL-1 targeting drugs has significantly modified the disease evolution. We aimed to evaluate the socio-professional impact of CAPS in the long term and the influence of genetic variants in the phenotype.

View Article and Find Full Text PDF

Introduction: Congenital hypothyroidism with gland-in-situ (CH-GIS) is usually attributed to mutations in the genes involved in thyroid hormone production. The diagnostic yield of targeted next-generation sequencing (NGS) varied widely between studies. We hypothesized that the molecular yield of targeted NGS would depend on the severity of CH.

View Article and Find Full Text PDF

Objectives: The TRI-SCORE reliably predicts in-hospital mortality after isolated tricuspid valve surgery (ITVS) on native valve but has not been tested in the setting of redo interventions. We aimed to evaluate the predictive value of the TRI-SCORE for in-hospital mortality in patients with redo ITVS and to compare its accuracy with conventional surgical risk scores.

Methods: Using a mandatory administrative database, we identified all consecutive adult patients who underwent a redo ITVS at 12 French tertiary centres between 2007 and 2017.

View Article and Find Full Text PDF

What Is This Summary About?: This article provides a short summary of 5-year results from the iNNOVATE trial. The original paper was published in the in October 2021. People with Waldenström's macroglobulinemia (WM) were randomly divided into two groups of 75 people each.

View Article and Find Full Text PDF

Significant coronary artery disease (CAD) is a frequent finding in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation (TAVI), and the management of these two conditions becomes of particular importance with the extension of the procedure to younger and lower-risk patients. Yet, the preprocedural diagnostic evaluation and the indications for treatment of significant CAD in TAVI candidates remain a matter of debate. In this clinical consensus statement, a group of experts from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) in collaboration with the European Society of Cardiology (ESC) Working Group on Cardiovascular Surgery aims to review the available evidence on the topic and proposes a rationale for the diagnostic evaluation and indications for percutaneous revascularisation of CAD in patients with severe aortic stenosis undergoing transcatheter treatment.

View Article and Find Full Text PDF

Etrasimod for the treatment of ulcerative colitis.

Immunotherapy

April 2023

University of Lorraine, CHRU-Nancy, Department of Gastroenterology, F-54000 Nancy, France.

Article Synopsis
  • Sphingosine-1-phosphate (S1P) and its receptor (S1PR) play a significant role in immune-related inflammatory diseases, particularly inflammatory bowel disease like ulcerative colitis.* -
  • Etrasimod is a new oral medication that selectively targets specific S1PRs, helping to prevent lymphocytes from moving into the bloodstream, which could lead to reduced inflammation.* -
  • Clinical studies, including the phase II OASIS trial, have shown that etrasimod is effective and safe for patients with moderate to severe ulcerative colitis, making it a promising treatment option.*
View Article and Find Full Text PDF

The dilemma of the disappearing colorectal liver metastases: defining international trends in management.

HPB (Oxford)

April 2023

Institute of Medical Sciences, University of Aberdeen, Scotland, UK; Department of HPB Surgery, NHS Grampian, Scotland, Aberdeen, UK; HPB Integrated Center of Care, Elite Integrated Centers of Excellence, Alexandria, Egypt. Electronic address:

Objective: This survey sought to appraise the degree of consistency in the management of disappeared colorectal liver metastases (dCRLM) among liver surgeons in different countries.

Background: Colorectal liver metastases (CRLM) account for half of the deaths secondary to colorectal cancer. Due to the high utilization of chemotherapy before surgery, some or all CRLM can disappear (dCRLM) but management of dCRLMs remains unclear.

View Article and Find Full Text PDF

Aim: The oral anti-angiogenic therapy nintedanib prolongs progression-free survival (PFS) when combined with chemotherapy after primary surgery for advanced epithelial ovarian cancer. The randomized phase II CHIVA trial evaluated the impact of combining nintedanib with neoadjuvant chemotherapy (NACT) for epithelial ovarian cancer.

Methods: Patients with newly diagnosed unresectable FIGO stage IIIC-IV epithelial ovarian cancer received 3-4 cycles of carboplatin plus paclitaxel every 3 weeks as NACT before interval debulking surgery (IDS), followed by 2-3 post-operative cycles.

View Article and Find Full Text PDF